AGILENT TECHNOLOGIES INC (A) Stock Price, Quote, News and Overview
NYSE:A - New York Stock Exchange, Inc. - US00846U1016 - Common Stock - Currency: USD
A Quote, Performance and Key Statistics
AGILENT TECHNOLOGIES INC
NYSE:A (1/30/2025, 2:00:54 PM)
152.12
+5.03 (+3.42%)
The current stock price of A is 152.12 USD. In the past month the price increased by 8.52%. In the past year, price increased by 10.62%.
A Latest News, Press Releases and Analysis
Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
Agilent Automated Workflows at SLAS2025: Connecting with Confidence
Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
A Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 28.38 | 232.59B | ||
| DHR | DANAHER CORP | 29.74 | 160.90B | ||
| IQV | IQVIA HOLDINGS INC | 18.54 | 36.54B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.91 | 28.91B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 51.22 | 25.08B | ||
| WAT | WATERS CORP | 36.8 | 24.89B | ||
| ILMN | ILLUMINA INC | 77.31 | 21.21B | ||
| ICLR | ICON PLC | 14.39 | 16.67B | ||
| RVTY | REVVITY INC | 26.87 | 15.47B | ||
| AVTR | AVANTOR INC | 22.71 | 15.15B | ||
| TECH | BIO-TECHNE CORP | 40.96 | 11.65B | ||
| MEDP | MEDPACE HOLDINGS INC | 31 | 11.00B |
Related stock screener links
About A
Company Profile
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 17,400 full-time employees. The company operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. The company also offers contract development and manufacturing organization (CDMO) services.
Company Info
AGILENT TECHNOLOGIES INC
5301 Stevens Creek Blvd
Santa Clara CALIFORNIA 95051 US
CEO: Michael R. McMullen
Employees: 17400
Company Website: https://www.agilent.com/
Investor Relations: https://www.investor.agilent.com
Phone: 14083458886
A FAQ
What is the stock price of A?
The current stock price of A is 152.12 USD.
What is the symbol for AGILENT TECHNOLOGIES INC stock?
The exchange symbol of AGILENT TECHNOLOGIES INC is A and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is A stock listed?
A stock is listed on the New York Stock Exchange, Inc. exchange.
Is A a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for A, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of A.
Does A stock pay dividends?
A has a dividend yield of 0.65%. The yearly dividend amount is currently 0.95.
What is the Price/Earnings (PE) ratio of A?
The PE ratio for A is 28.76. This is based on the reported non-GAAP earnings per share of 5.29 and the current share price of 152.12 USD.
What is the Short Interest ratio of A stock?
The outstanding short interest for A is 1.02% of its float.
A Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to A. When comparing the yearly performance of all stocks, A turns out to be only a medium performer in the overall market: it outperformed 65.2% of all stocks.
A Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to A. Both the health and profitability get an excellent rating, making A a very profitable company, without any liquidiy or solvency issues.
A Financial Highlights
Over the last trailing twelve months A reported a non-GAAP Earnings per Share(EPS) of 5.29. The EPS increased by -2.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.8% | ||
| ROA | 10.88% | ||
| ROE | 21.85% | ||
| Debt/Equity | 0.57 |
A Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to A. The Buy consensus is the average rating of analysts ratings from 27 analysts.
For the next year, analysts expect an EPS growth of 7.33% and a revenue growth 5.46% for A